Mode
Text Size
Log in / Sign up

Review of single-stage surgery for orbital and parasellar infantile hemangioma in a 55-day-old infant

Review of single-stage surgery for orbital and parasellar infantile hemangioma in a 55-day-old infan…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider surgical resection for solitary orbital/parasellar IH with diagnostic uncertainty and significant symptomatology, noting limited generalizability.

This publication is a case report detailing the management of a 55-day-old female infant presenting with orbital and intracranial infantile hemangioma. The intervention involved a single-stage left pterional approach designed for the simultaneous resection of both orbital and parasellar lesions. The setting and specific follow-up duration were not reported in the source text. The primary outcomes assessed included achieving a definitive histopathological diagnosis and providing relief of mass effect. Secondary outcomes focused on the resolution of proptosis, the status of neurological deficits, and the extent of lesion resection.

The main results indicated that histopathological examination confirmed the diagnosis of cellular infantile hemangioma. Following the procedure, the patient experienced complete resolution of proptosis and no neurological deficits. Additionally, total resection of the lesions was achieved. The safety profile was characterized by an uneventful recovery, with no adverse events, serious adverse events, or discontinuations reported. However, the sample size was one, which inherently limits the statistical power and generalizability of these specific outcomes.

The authors acknowledge a key limitation: the absence of a management consensus for solitary orbital and parasellar infantile hemangiomas without cutaneous manifestations. Consequently, while the practice relevance suggests that isolated intracranial or orbital infantile hemangioma should be included in the differential diagnosis of pediatric masses even without skin involvement, the evidence is restricted to this single case. Surgical resection may be considered a safe and effective primary strategy when facing diagnostic uncertainty and significant symptomatology, but clinicians should interpret these results with caution given the lack of broader comparative data.

Study Details

Study typeGuideline
EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
BackgroundSolitary orbital and parasellar infantile hemangiomas (IHs) without cutaneous manifestations are exceptionally rare, posing significant diagnostic and therapeutic challenges due to the absence of management consensus.Case presentationA 55-day-old female infant presented with progressive left-sided proptosis over the course of one month. Preoperative magnetic resonance imaging (MRI) revealed homogeneously enhancing masses in the left orbit (encasing the optic nerve) and the parasellar region, in which imaging characteristics resembled those of a meningioma. No cutaneous lesions or features of PHACE syndrome were identified. Following multidisciplinary team consultation, a single-stage left pterional approach for the simultaneous resection of both the orbital and parasellar lesions, with the aim of establishing a definitive histopathological diagnosis and relieving mass effect. Histopathological examination confirmed the diagnosis of cellular IH, which could be supported by characteristic morphology and positive immunohistochemical staining for GLUT-1 and CD31. Postoperative recovery was uneventful, with complete resolution of proptosis and no neurological deficits. Imaging confirmed total resection of both lesions.ConclusionsThis case emphasizes that isolated intracranial/orbital IH should be included in the differential diagnosis of pediatric masses, even in the absence of skin involvement. When facing diagnostic uncertainty and significant symptomatology, surgical resection can be a safe and effective primary strategy, providing definitive diagnosis and immediate decompression.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.